Abstract

Background: There is a growing population of patients with chronic kidney disease (CKD) with a high burden of comorbidities and complications that require multiple medications which puts them at risk of medication-related problems (MRPs). This study aims to identify and describe the types of MRPs in CKD patients. Methods: Current medical records of CKD patients attending the renal clinic of a tertiary hospital in Lagos were reviewed to retrieve data on patient demographics, diagnosis, and medication prescribed. The identifified MRPs were categorized using the Pharmaceutical Care Network Europe classifification of drug-related problem tool (PCNE DRP). Multivariate regression was utilized to assess the association between the dependent (MRPs) and independent variables (number of comorbidities, doses per day, medications, age, and stage of CKD). Statistical signifificance was set at p < 0.05. Results: MRPs were identifified and categorized in 89 patients (1.54 ± 0.66 MRPs/patient). The prevalent MRPs identifified were drug use problems (38.4%), adverse drug reactions (16.2%), drug choice problems (14.1%) and dosing problems (12.1%). The odds of identifying MRPs increased with number of comorbidities [AOR 3.71 (95% CI 1.15-11.98); P<0.002], number of medications [OR 4.03(95% CI 1.53-10.65); P <0.0001], and number of doses per day [AOR 4.02 (95% CI 1.49-10.89); P <0.0001]. Conclusion: Medication-Related Problems in CKD patients are high, mandating the need for scheduled review by hospital pharmacists to identify and make interventions with the knowledge of the attending clinicians.&nbsp

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.